TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Efficacy and Safety of a 3-Antigen (Pre-S1/Pre-S2/S) Hepatitis B Vaccine: Results of a Phase 3 Randomized Clinical Trial in the Russian Federation.

Elena V Esaulenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.